1
|
Minich DM, Ross K, Frame J, Fahoum M, Warner W, Meissner HO. Not All Maca Is Created Equal: A Review of Colors, Nutrition, Phytochemicals, and Clinical Uses. Nutrients 2024; 16:530. [PMID: 38398854 PMCID: PMC10892513 DOI: 10.3390/nu16040530] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2023] [Revised: 01/09/2024] [Accepted: 01/17/2024] [Indexed: 02/25/2024] Open
Abstract
Maca (Lepidium meyenii, Lepidium peruvianum) is part of the Brassicaceae family and grows at high altitudes in the Peruvian Andes mountain range (3500-5000 m). Historically, it has been used as a nutrient-dense food and for its medicinal properties, primarily in enhancing energy and fertility. Scientific research has validated these traditional uses and other clinical applications by elucidating maca's mechanisms of action, nutrition, and phytochemical content. However, research over the last twenty years has identified up to seventeen different colors (phenotypes) of maca. The color, hypocotyl size, growing location, cultivation, and post-harvest processing methods can have a significant effect on the nutrition content, phytochemical profile, and clinical application. Yet, research differentiating the colors of maca and clinical applications remains limited. In this review, research on the nutrition, phytochemicals, and various colors of maca, including black, red, yellow (predominant colors), purple, gray (lesser-known colors), and any combination of colors, including proprietary formulations, will be discussed based on available preclinical and clinical trials. The gaps, deficiencies, and conflicts in the studies will be detailed, along with quality, safety, and efficacy criteria, highlighting the need for future research to specify all these factors of the maca used in publications.
Collapse
Affiliation(s)
- Deanna M. Minich
- Human Nutrition and Functional Medicine, Adjunct Faculty, University of Western States, Portland, OR 97213, USA
- Food & Spirit, LLC, Port Orchard, WA 98366, USA
- Symphony Natural Health, Inc., West Valley City, UT 84119, USA; (K.R.); (M.F.); (W.W.)
- Symphony Natural Health Institute, West Valley City, UT 84119, USA
| | - Kim Ross
- Symphony Natural Health, Inc., West Valley City, UT 84119, USA; (K.R.); (M.F.); (W.W.)
- Symphony Natural Health Institute, West Valley City, UT 84119, USA
- Kim Ross Consulting, LLC, Lakewood Ranch, FL 34211, USA
- College of Nutrition, Sonoran University of Health Sciences, Tempe, AZ 85282, USA
| | - James Frame
- Symphony Natural Health Holdings Inc., Craigmuir Chambers, Road Town, Tortola VG1110, (BVI), UK;
- Natural Health International Pty Ltd., Sydney, NSW 2000, Australia
| | - Mona Fahoum
- Symphony Natural Health, Inc., West Valley City, UT 84119, USA; (K.R.); (M.F.); (W.W.)
- Meridian Medicine, Seattle, WA 98133, USA
- Bastyr Center for Natural Health, Bastyr University, Kenmore, WA 98028, USA
| | - Wendy Warner
- Symphony Natural Health, Inc., West Valley City, UT 84119, USA; (K.R.); (M.F.); (W.W.)
- Wendy Warner, MD, PC, Yardley, PA 19067, USA
| | - Henry O. Meissner
- National Institute of Complementary Medicine, Health Research Institute, Western Sydney University, Building J, 158-160 Hawkesbury Road, Westmead, NSW 2145, Australia;
- Therapeutic Research, TTD International Pty Ltd., 39 Leopard Ave., Elanora-Gold Coast, QLD 4221, Australia
| |
Collapse
|
2
|
Aguilar-Galvez A, García-Ríos D, Ramírez-Guzmán D, Lindo J, Chirinos R, Pedreschi R, Campos D. In vitro and in vivo biotransformation of glucosinolates from mashua (Tropaeolum tuberosum) by lactic acid bacteria. Food Chem 2023; 404:134631. [DOI: 10.1016/j.foodchem.2022.134631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2022] [Revised: 09/16/2022] [Accepted: 10/13/2022] [Indexed: 11/06/2022]
|
5
|
The Distribution of Glucosinolates in Different Phenotypes of Lepidium peruvianum and Their Role as Acetyl- and Butyrylcholinesterase Inhibitors-In Silico and In Vitro Studies. Int J Mol Sci 2022; 23:ijms23094858. [PMID: 35563248 PMCID: PMC9101689 DOI: 10.3390/ijms23094858] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2022] [Revised: 04/22/2022] [Accepted: 04/25/2022] [Indexed: 11/17/2022] Open
Abstract
The aim of the study was to present the fingerprint of different Lepidium peruvianum tuber extracts showing glucosinolates-containing substances possibly playing an important role in preventinting dementia and other memory disorders. Different phenotypes of Lepidium peruvianum (Brassicaceae) tubers were analysed for their glucosinolate profile using a liquid chromatograph coupled with mass spectrometer (HPLC-ESI-QTOF-MS/MS platform). Qualitative analysis in 50% ethanolic extracts confirmed the presence of ten compounds: aliphatic, indolyl, and aromatic glucosinolates, with glucotropaeolin being the leading one, detected at levels between 0–1.57% depending on phenotype, size, processing, and collection site. The PCA analysis showed important variations in glucosinolate content between the samples and different ratios of the detected compounds. Applied in vitro activity tests confirmed inhibitory properties of extracts and single glucosinolates against acetylcholinesterase (AChE) (15.3–28.9% for the extracts and 55.95–57.60% for individual compounds) and butyrylcholinesterase (BuChE) (71.3–77.2% for the extracts and 36.2–39.9% for individual compounds). The molecular basis for the activity of glucosinolates was explained through molecular docking studies showing that the tested metabolites interacted with tryptophan and histidine residues of the enzymes, most likely blocking their active catalytic side. Based on the obtained results and described mechanism of action, it could be concluded that glucosinolates exhibit inhibitory properties against two cholinesterases present in the synaptic cleft, which indicates that selected phenotypes of L. peruvianum tubers cultivated under well-defined environmental and ecological conditions may present a valuable plant material to be considered for the development of therapeutic products with memory-stimulating properties.
Collapse
|
6
|
Oral Supplementation with Benzylamine Delays the Onset of Diabetes in Obese and Diabetic db-/- Mice. Nutrients 2021; 13:nu13082622. [PMID: 34444782 PMCID: PMC8401126 DOI: 10.3390/nu13082622] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2021] [Revised: 07/27/2021] [Accepted: 07/27/2021] [Indexed: 12/19/2022] Open
Abstract
Substrates of semicarbazide-sensitive amine oxidase (SSAO) exert insulin-like actions in adipocytes. One of them, benzylamine (Bza) exhibits antihyperglycemic properties in several rodent models of diabetes. To further study the antidiabetic potential of this naturally occurring amine, a model of severe type 2 diabetes, the obese db-/- mouse, was subjected to oral Bza administration. To this end, db-/- mice and their lean littermates were treated at 4 weeks of age by adding 0.5% Bza in drinking water for seven weeks. Body mass, fat content, blood glucose and urinary glucose output were followed while adipocyte insulin responsiveness and gene expression were checked at the end of supplementation, together with aorta nitrites. Bza supplementation delayed the appearance of hyperglycemia, abolished polydypsia and glycosuria in obese/diabetic mice without any detectable effect in lean control, except for a reduction in food intake observed in both genotypes. The improvement of glucose homeostasis was observed in db-/- mice at the expense of increased fat deposition, especially in the subcutaneous white adipose tissue (SCWAT), without sign of worsened inflammation or insulin responsiveness and with lowered circulating triglycerides and uric acid, while NO bioavailability was increased in aorta. The higher capacity of SSAO in oxidizing Bza in SCWAT, found in the obese mice, was unaltered by Bza supplementation and likely involved in the activation of glucose utilization by adipocytes. We propose that Bza oxidation in tissues, which produces hydrogen peroxide mainly in SCWAT, facilitates insulin-independent glucose utilization. Bza could be considered as a potential agent for dietary supplementation aiming at preventing diabetic complications.
Collapse
|